By GMA News
Published January 11, 2022 1:20am
The Food and Drug Administration has granted the Department of Health’s application for compassionate special permit for Bexovid, the generic and more affordable version of Pfizer’s anti-COVID-19 Paxlovid.
FDA director general Dr. Oscar Gutierrez said the less pricey anti-viral would be distributed government hospitals.
In President Rodrigo Duterte’s Talk to the People, Gutierrez said the FDA has received two product applications for self-administered COVID-19 test kits.
Bexovid is the word’s first generic version of the US FDA-approved brand Paxlovid made by Pfizer. Its generic name is nirmatrelvir and ritonavir.
According to Gutierrez’s presentation, Bexovid is made by Beximco Pharm, Inc. and will be distributed in the Philippines by Biocare Lifescience, Inc.
The treatment is said to resuce the risk of hospitalization or death by 89% if given within 3 says of the onset of symptoms and by 88% if given within 5. –NB, GMA News